Friday, January 31, 2025
spot_img

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two upcoming investor conferences:

  • The Guggenheim SMID Cap Biotech Conference on Thursday, February 6th, at 6:00 a.m. PT / 9:00 a.m. ET
  • The Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12th, at 7:00 a.m. PT / 10:00 a.m. ET

A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution, 0.25%) is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
[email protected]

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
[email protected]

Powered by SlickText.com

Hot this week

Dividend Growth Split Corp. Renews At-The-Market Equity Program

Not for distribution to U.S. newswire services or for...

AMG to Announce Fourth-Quarter and Full-Year Results on February 6, 2025

Conference Call Scheduled for 8:30 a.m. Eastern Time ...

Prospera Energy Inc. Provides Update on Future Production Reporting Process

CALGARY, Alberta, Jan. 31, 2025 (GLOBE NEWSWIRE)...

Urgently Announces Short-Term Extensions of Term Loans

Extensions support capital structure improvements and refinancing effortsVIENNA, Va.,...

Topics

Dividend Growth Split Corp. Renews At-The-Market Equity Program

Not for distribution to U.S. newswire services or for...

AMG to Announce Fourth-Quarter and Full-Year Results on February 6, 2025

Conference Call Scheduled for 8:30 a.m. Eastern Time ...

Urgently Announces Short-Term Extensions of Term Loans

Extensions support capital structure improvements and refinancing effortsVIENNA, Va.,...

AlphaGen Announces Securities for Debt Settlement

VANCOUVER, British Columbia, Jan. 31, 2025 (GLOBE...
spot_img

Related Articles

Popular Categories

spot_img